Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $2.08, for a total value of $15,600.00. Following the completion of the sale, the chief executive officer now owns 224,733 shares of […]
Client 1ST Advisory Group LLC reduced its holdings in shares of iShares MSCI USA Value Factor ETF (BATS:VLUE – Free Report) by 14.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,400 shares of the company’s stock after selling 2,587 shares during the […]
Client 1ST Advisory Group LLC reduced its holdings in shares of iShares MSCI USA Value Factor ETF (BATS:VLUE – Free Report) by 14.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,400 shares of the company’s stock after selling 2,587 shares during the […]
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, an increase of 11.5% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 276,300 shares, the days-to-cover […]
Dimensional Fund Advisors LP raised its stake in shares of Albertsons Companies, Inc. (NYSE:ACI – Free Report) by 40.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,404,574 shares of the company’s stock after acquiring an additional 692,188 shares during the quarter. Dimensional […]